TrademarkDir
Serial #76339465
DEAD

Serial Number

76339465

Owner

EXPRESS SCRIPTS, INC.

Attorney

Troy E. Larson

Filing Date

Nov 19, 2001

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #76339465 Trademark

Serial Number: 76339465 • Registration: 2948670

Serial #76339465 is a trademark filed by EXPRESS SCRIPTS, INC. on November 19, 2001. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

EXPRESS SCRIPTS, INC. (128 trademarks)

2369 SCHUETZ ROAD
ST. LOUIS, MO 63146

Entity Type: 03

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

PRIORITY HEALTHCARE CORPORATION (31 trademarks)

4212 West 71st Street
Indianapolis, IN 46268

Entity Type: 03

Trademark Details

Filing Date

November 19, 2001

Registration Date

May 10, 2005

Published for Opposition

April 16, 2002

Cancellation Date

November 21, 2025

Goods & Services

Retail pharmacy services featuring infertility pharmaceuticals and prescription compounding

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Nov 21, 2025 CAEX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2024 REAP
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 10, 2024 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2019 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 5, 2017 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 18, 2015 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 18, 2015 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 18, 2015 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 14, 2015 APRE
TEAS SECTION 8 & 9 RECEIVED
Apr 28, 2015 E89R
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 23, 2012 REAP
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 23, 2010 C15A
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 22, 2010 ASGN
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 22, 2010 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 21, 2010 E815
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 9, 2006 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 9, 2006 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2006 TCCA
REGISTERED-PRINCIPAL REGISTER
May 10, 2005 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Feb 17, 2005 REGV
ASSIGNED TO LIE
Feb 11, 2005 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 25, 2005 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 24, 2005 SUPC
SOU EXTENSION 5 GRANTED
Jan 24, 2005 EX5G
PAPER RECEIVED
Jan 10, 2005 MAIL
USE AMENDMENT FILED
Jan 6, 2005 IUAF
SOU EXTENSION 5 FILED
Jan 6, 2005 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 6, 2005 EEXT
SOU EXTENSION 4 GRANTED
Aug 3, 2004 EX4G
CASE FILE IN TICRS
Jul 15, 2004 CFIT
SOU EXTENSION 4 FILED
Jul 8, 2004 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 8, 2004 EEXT
SOU EXTENSION 3 GRANTED
Feb 2, 2004 EX3G
SOU EXTENSION 3 FILED
Jan 8, 2004 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 8, 2004 EEXT
SOU EXTENSION 2 GRANTED
Jul 29, 2003 EX2G
SOU EXTENSION 2 FILED
Jul 8, 2003 EXT2
PAPER RECEIVED
Jul 8, 2003 MAIL
SOU EXTENSION 1 GRANTED
Apr 3, 2003 EX1G
PAPER RECEIVED
Jan 6, 2003 MAIL
SOU EXTENSION 1 FILED
Jan 3, 2003 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 9, 2002 NOAM
PUBLISHED FOR OPPOSITION
Apr 16, 2002 PUBO
NOTICE OF PUBLICATION
Mar 27, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2002 CNSA
ASSIGNED TO EXAMINER
Feb 1, 2002 DOCK
ASSIGNED TO EXAMINER
Jan 30, 2002 DOCK

Related Trademarks

More from this Owner

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE